• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药用熊果酸衍生物:专利综述(2012 - 2016年)

Ursolic acid derivatives for pharmaceutical use: a patent review (2012-2016).

作者信息

Hussain Hidayat, Green Ivan R, Ali Iftikhar, Khan Ikhlas A, Ali Zulfiqar, Al-Sadi Abdullah M, Ahmed Ishtiaq

机构信息

a UoN Chair of Oman's Medicinal Plants and Marine Natural Products , University of Nizwa , Nizwa , Sultanate of Oman.

b Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography , University of California , San Diego , CA , USA.

出版信息

Expert Opin Ther Pat. 2017 Sep;27(9):1061-1072. doi: 10.1080/13543776.2017.1344219. Epub 2017 Jun 30.

DOI:10.1080/13543776.2017.1344219
PMID:28637397
Abstract

Ursolic acid (UA), belongs to a group of pentacyclic triterpenoids and is known to possess some very interesting biological properties. Protocols have been developed in order to synthesize bioactive UA analogs which have resulted in numerous ursolic acid analogs being synthesized during the period 2012-2016. Ursolic acid and its analogues can be employed to treat various cancers, inflammatory diseases, diabetes, Parkinson's disease, Alzheimer's disease, hepatitis B, hepatitis C and AIDS to mention but a few. Areas covered: This review covers patents on therapeutic activities of ursolic acid (UA) and its synthetic derivatives published during the four year period 2012-2016. A discussion about structure-activity relationships (SAR) of these analogs is also included. Expert opinion: Ursolic acid and its synthetic derivatives demonstrated excellent anticancer, antidiabetic, antiarrhythmic, anti-hyperlipidemic, antimicrobial, anti-hypercholesterolemic, and anti-cardiovascular properties. Additionally, various ursolic acid analogues have been synthesized through modification at positions C-OH, C-OH and CCOH. It is noteworthy that the C-17 amide and amino analogs of UA possessed better anticancer activity compared to the parent compound (UA). Most importantly, UA has the potential to conjugate with other anticancer drugs or be transformed into its halo derivatives since this will greatly facilitate scientists to get lead compounds in cancer drug discovery.

摘要

熊果酸(UA)属于五环三萜类化合物,已知具有一些非常有趣的生物学特性。人们已经开发出了合成具有生物活性的UA类似物的方法,这使得在2012年至2016年期间合成了大量熊果酸类似物。熊果酸及其类似物可用于治疗多种癌症、炎症性疾病、糖尿病、帕金森病、阿尔茨海默病、乙型肝炎、丙型肝炎和艾滋病等等。涵盖领域:本综述涵盖了2012年至2016年这四年期间发表的关于熊果酸(UA)及其合成衍生物治疗活性的专利。还包括对这些类似物的构效关系(SAR)的讨论。专家观点:熊果酸及其合成衍生物表现出优异的抗癌、抗糖尿病、抗心律失常、抗高血脂、抗菌、抗高胆固醇血症和抗心血管特性。此外,通过对C-OH、C-OH和CCOH位置进行修饰合成了各种熊果酸类似物。值得注意的是,与母体化合物(UA)相比,UA的C-17酰胺和氨基类似物具有更好的抗癌活性。最重要的是,UA有可能与其他抗癌药物缀合或转化为其卤代衍生物,因为这将极大地促进科学家在癌症药物发现中获得先导化合物。

相似文献

1
Ursolic acid derivatives for pharmaceutical use: a patent review (2012-2016).药用熊果酸衍生物:专利综述(2012 - 2016年)
Expert Opin Ther Pat. 2017 Sep;27(9):1061-1072. doi: 10.1080/13543776.2017.1344219. Epub 2017 Jun 30.
2
Therapeutic potential of boswellic acids: a patent review (1990-2015).乳香酸的治疗潜力:专利综述(1990 - 2015年)
Expert Opin Ther Pat. 2017 Jan;27(1):81-90. doi: 10.1080/13543776.2017.1235156. Epub 2016 Sep 20.
3
Therapeutic potential of glycyrrhetinic acids: a patent review (2010-2017).甘草次酸的治疗潜力:专利研究综述(2010-2017)。
Expert Opin Ther Pat. 2018 May;28(5):383-398. doi: 10.1080/13543776.2018.1455828. Epub 2018 Mar 26.
4
Usnic acid and its derivatives for pharmaceutical use: a patent review (2000-2017).地衣酸及其衍生物在药物中的应用:专利研究综述(2000-2017)。
Expert Opin Ther Pat. 2018 Jun;28(6):477-491. doi: 10.1080/13543776.2018.1472239. Epub 2018 May 9.
5
Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs.新型熊果酸衍生物作为潜在抗癌前药的合成及生物学评价
Chem Biol Drug Des. 2015 Dec;86(6):1397-404. doi: 10.1111/cbdd.12608. Epub 2015 Jul 14.
6
Cucurbitacins as Anticancer Agents: A Patent Review.葫芦素类化合物作为抗癌剂:专利研究综述。
Recent Pat Anticancer Drug Discov. 2019;14(2):133-143. doi: 10.2174/1574892813666181119123035.
7
Clinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural product.具有临床应用价值的抗癌、抗肿瘤和抗皱剂,熊果酸及其相关衍生物作为有重要药用价值的天然产物。
J Enzyme Inhib Med Chem. 2011 Oct;26(5):616-42. doi: 10.3109/14756366.2010.546793. Epub 2011 Mar 22.
8
Synthesis and antitumor activity evaluation of novel ursolic acid derivatives.新型熊果酸衍生物的合成与抗肿瘤活性评价
J Asian Nat Prod Res. 2016;18(3):280-8. doi: 10.1080/10286020.2015.1070830. Epub 2015 Nov 3.
9
Therapeutic potential of boswellic acids: an update patent review (2016-2023).乳香酸的治疗潜力:更新的专利审查(2016-2023 年)。
Expert Opin Ther Pat. 2024 Aug;34(8):723-732. doi: 10.1080/13543776.2024.2369626. Epub 2024 Jul 5.
10
Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.齐墩果烷型、乌苏烷型和亚甲基醌型木栓烷型三萜衍生物:癌症治疗的最新进展
Eur J Med Chem. 2017 Dec 15;142:95-130. doi: 10.1016/j.ejmech.2017.07.013. Epub 2017 Jul 14.

引用本文的文献

1
Progress of ursolic acid on the regulation of macrophage: summary and prospect.熊果酸对巨噬细胞调节作用的研究进展:综述与展望
Front Immunol. 2025 May 12;16:1576771. doi: 10.3389/fimmu.2025.1576771. eCollection 2025.
2
Ursolic acid derivatives improved clinical signs of experimental autoimmune encephalomyelitis by modulating central nervous system inflammation.熊果酸衍生物通过调节中枢神经系统炎症改善了实验性自身免疫性脑脊髓炎的临床症状。
Metab Brain Dis. 2025 Apr 1;40(4):166. doi: 10.1007/s11011-025-01591-0.
3
Recent developments on ursolic acid and its potential biological applications.
熊果酸及其潜在生物学应用的最新进展。
Toxicol Rep. 2025 Jan 10;14:101900. doi: 10.1016/j.toxrep.2025.101900. eCollection 2025 Jun.
4
Essential Oils as Alternative Green Broad-Spectrum Biocides.精油作为替代性绿色广谱杀菌剂
Plants (Basel). 2024 Dec 8;13(23):3442. doi: 10.3390/plants13233442.
5
Phytochemical compounds for treating hyperuricemia associated with gout: a systematic review.用于治疗痛风相关高尿酸血症的植物化学化合物:一项系统评价
Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):4779-4801. doi: 10.1007/s00210-024-03686-4. Epub 2024 Dec 5.
6
Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges.熊果酸作为一种新型抗结核药物的前景:当前进展和挑战。
Drug Des Devel Ther. 2024 May 31;18:1969-1979. doi: 10.2147/DDDT.S454399. eCollection 2024.
7
Evaluation of the mechanistic basis for the antibacterial activity of ursolic acid against .熊果酸对……抗菌活性的作用机制基础评估
Front Microbiol. 2024 May 17;15:1389242. doi: 10.3389/fmicb.2024.1389242. eCollection 2024.
8
Ursolic Acid Formulations Effectively Induce Apoptosis and Limit Inflammation in the Psoriasis Models In Vitro.熊果酸制剂在体外银屑病模型中有效诱导细胞凋亡并限制炎症。
Biomedicines. 2024 Mar 25;12(4):732. doi: 10.3390/biomedicines12040732.
9
Phytochemistry, Bioactivity, and Ethnopharmacology of the Genus Willd. (Lamiaceae): A Review.威尔德属(唇形科)的植物化学、生物活性及民族药理学:综述
Plants (Basel). 2024 Feb 8;13(4):481. doi: 10.3390/plants13040481.
10
Evaluation of A-ring hydroxymethylene-amino- triterpenoids as inhibitors of SARS-CoV-2 spike pseudovirus and influenza H1N1.评估 A 环羟亚甲基-氨基-三萜类化合物作为 SARS-CoV-2 刺突假病毒和流感 H1N1 的抑制剂。
J Antibiot (Tokyo). 2024 Jan;77(1):39-49. doi: 10.1038/s41429-023-00677-0. Epub 2023 Nov 24.